Table 1: Demographic,
anthropometric, laboratory and patients’ disease SLE in crossover study before
starting treatment and placebo.
Characteristics |
Mean (N = 29) |
Range |
Standard deviation |
Age
(years) |
33.66 |
20-54 |
8.60 |
Ilness duration
(months) |
93.83 |
6-296 |
72.62 |
Age of
diagnosis |
25.83 |
17-48 |
7.67 |
Education
(years) |
10.41 |
4-17 |
3.15 |
Number of
medications in use |
3.21 |
1-7 |
1.61 |
SLICC |
0.36 |
0-5 |
0.98 |
SLEDAI |
3.85 |
0-10 |
3.09 |
DNA damage
index (%) |
43.38 |
29.50-60.50 |
7.08 |
BMI (kg/m2) |
24.05 |
17.26-43.70 |
5.51 |
Waist
circumference (cm) |
88.82 |
73.50-135 |
13.71 |
Hip
circumference (cm) |
98.91 |
82-139 |
10.55 |
Waist-hip
ratio |
0.87 |
0.79-0.87 |
0.048 |
Adequacy
AC (%) |
101.18% |
80.06-146.85 |
13.35 |
Adequacy
TS (%) |
109.26 |
58.82-204.44 |
30.87 |
Adequacy AMC(%) |
100.04 |
88.34-129.95 |
9.24 |
Hemoglobin
g/dl |
13.29 |
11.6-15.10 |
0.87 |
Creatinine
mg/dL |
0.65 |
0.5-1.0 |
0.095 |
Complement
C3 mg/dL |
96.18 |
52.9-159 |
26.44 |
Complement
C4 mg/dL |
16.74 |
3.70-42.60 |
7.83 |
Total
cholesterol mg/dL |
167.61 |
116-219 |
25.23 |
Triglycerides
mg/dL |
113.11 |
50-251 |
45.90 |
HDL mg/dL |
45.50 |
22-69 |
11.41 |
LDL mg/dL |
99.49 |
60.40-147.20 |
22.97 |
VLDL mg/dL |
22.61 |
10-50 |
9.16 |
Albumin g/dL |
4.20 |
3.80-4.90 |
0.25 |
hs-CRP mg/dL |
0.30 |
0.09-1.5 |
0.32 |
SLICC: Systemic Lupus International Collaborating Clinics; SLEDAI:
Systemic Lupus Erythematosus Disease Activity Index;
BMI: Body Mass Index; AC: Arm Circumference;
TS: Triceps Skinfold; AMC: Arm Muscle Circumference; HDL: High-Density Lipoprotein; LDL: Low-Density Lipoprotein; VLDL: Very-Low-Density Lipoprotein; hs-CRP: high-sensitivity C-reactive protein (hs-CRP).